Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1Phase 2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 498Rectal Neoplasms 268Colonic Neoplasms 219Pancreatic Neoplasms 190Stomach Neoplasms 183Esophageal Neoplasms 135Neoplasm Metastasis 98Adenocarcinoma Of Esophagus 67Esophageal Squamous Cell Carcinoma 62Carcinoma, Hepatocellular 56Neoplasms 44Cholangiocarcinoma 33Biliary Tract Neoplasms 27Adenocarcinoma 27Anus Neoplasms 26Gastrointestinal Neoplasms 25Gallbladder Neoplasms 22Liver Neoplasms 21Carcinoma, Non-Small-Cell Lung 20Bile Duct Neoplasms 19Parkinson Disease 4, Autosomal Dominant Lewy Body 16Ovarian Neoplasms 11Digestive System Neoplasms 10Colorectal Cancer Metastatic 10Carcinoma, Squamous Cell 10Peritoneal Neoplasms 9Breast Neoplasms 9Anal Canal Carcinoma 9Lung Neoplasms 8Head and Neck Neoplasms 8

Interventions

Oxaliplatin 3Fluorouracil 3Radiotherapy 2Immune Checkpoint Inhibitors 2Endoscopy 2Drug Therapy 2Chemoradiotherapy 2toripalimab 1tislelizumab 1pembrolizumab 1X-Rays 1Tretinoin 1TP protocol 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Proctectomy 1Positron Emission Tomography Computed Tomography 1Neoadjuvant Therapy 1Magnetic Resonance Imaging 1Leucovorin 1Immunotherapy 1Immunohistochemistry 1Esophagectomy 1Epirubicin 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Docetaxel 1Diffusion Magnetic Resonance Imaging 1Cisplatin 1Capecitabine 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Pathologic Complete Response × Fluorouracil × Gastrointestinal × Clear all
NCT05000697 2024-11-27

CCHOWW

Hospital Alemão Oswaldo Cruz

Phase NA Recruiting
216 enrolled
Gastrointestinal

Pathologic Complete Response, Rectal Neoplasms

NCT01216644 2019-06-19

5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer

Krankenhaus Nordwest

Phase 2/3 Completed
716 enrolled
Gastrointestinal

Pathologic Complete Response, Stomach Neoplasms

NCT02353858 2018-02-13

HT01

University Hospital Tuebingen

Phase 2 Completed
78 enrolled
Gastrointestinal

Hyperthermia, Pathologic Complete Response, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡